AstraZeneca resumes US COVID-19 vaccine trial as J&J prepares to do same
AstraZeneca paused its US trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.(photo credit: REUTERS/DADO RUVIC)ByREUTERS
